Durham pharma Novan slashes 50% of workforce, mulls sale of assets
Drug development firm Novan is cutting 50% of its workforce – 39 employees – and is looking to sell or license some of its product lines.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
